Q4 2024 Grail Inc Earnings Call Transcript

Feb 20, 2025 / 09:30 PM GMT

Release Date Price: €47.4 (+5.80%)

Transcript 10-K8-K

Key Points

Positve

GRAIL Inc (GRAL) reported a 26% increase in revenue for Q4 2024, reaching $38.3 million compared to Q4 2023.
The company achieved a 45% year-over-year growth in US gallery revenue, selling over 137,000 gallery tests.
GRAIL Inc (GRAL) successfully integrated its test ordering system with Quest Diagnostics, facilitating easier access for physicians and patients.
The US military's TriCare Health Insurance Program added the gallery test as a covered benefit for eligible patients, expanding potential market reach.
The company has extended its cash runway into 2028, providing financial stability to achieve major milestones, including FDA submissions.

Negative

GRAIL Inc (GRAL) reported a net loss of $97.1 million for Q4 2024, although this was an improvement from the previous year.
The full-year net loss increased by 38% to $2 billion, primarily due to goodwill and intangible asset impairments.
Development services revenue decreased by 13% in Q4 2024 compared to the same period in 2023.
The company faces uncertainty related to the timing and approval of the MCED legislation, which could impact future reimbursement rates.
There is no immediate impact from recent AI and cancer detection initiatives, indicating potential long-term rather than short-term benefits.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GRAL.OQ - Grail Inc
Q4 2024 Grail Inc Earnings Call
Feb 20, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day ladies and gentlemen, and welcome to the Gray 4th quarter 2024 earnings call. At this time, all participants are in listen-only mode. After the speaker's presentation, there'll be a question and answer session.

Please be advised that this conference call is being recorded.

Grell Investor relations, please begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you and thank you all for joining us today. On the caller, Boragusa, our Chief Executive Officer, Aaron Frieden, our Chief Financial Officer, Doctor Joshua Hoffman, our President.

And Sir Harpo Kumar,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.